Cite
HARVARD Citation
Ma, D. et al. (2016). Clinical effect of pemetrexed as the first‐line treatment in Chinese patients with advanced anaplastic lymphoma kinase‐positive non‐small cell lung cancer. Thoracic cancer. 7 (4), pp. 452-458. [Online].